Alphatec Holdings [ATEC] vs Bio-Rad [BIO.B] Detailed Stock Comparison
Alphatec Holdings
NASDAQ
Loading...
Bio-Rad
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Alphatec Holdings wins in 5 metrics, Bio-Rad wins in 13 metrics, with 0 ties. Bio-Rad appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Alphatec Holdings | Bio-Rad | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -12.35 | 25.71 | Alphatec Holdings |
| Price-to-Book Ratio | 86.17 | 1.08 | Bio-Rad |
| Debt-to-Equity Ratio | 1,238.29 | 19.73 | Bio-Rad |
| PEG Ratio | 1.79 | -0.22 | Bio-Rad |
| EV/EBITDA | -167.82 | 18.87 | Alphatec Holdings |
| Profit Margin (TTM) | -24.33% | 12.50% | Bio-Rad |
| Operating Margin (TTM) | -6.19% | 12.19% | Bio-Rad |
| EBITDA Margin (TTM) | N/A | 12.19% | N/A |
| Return on Equity | -376.89% | 4.59% | Bio-Rad |
| Return on Assets (TTM) | -7.61% | 1.59% | Bio-Rad |
| Free Cash Flow (TTM) | $-137.79M | $266.20M | Bio-Rad |
| 1-Year Return | 164.08% | -14.92% | Alphatec Holdings |
| Price-to-Sales Ratio (TTM) | 3.03 | 3.10 | Alphatec Holdings |
| Enterprise Value | $2.52B | $7.74B | Bio-Rad |
| EV/Revenue Ratio | 3.69 | 3.03 | Bio-Rad |
| Gross Profit Margin (TTM) | 69.58% | 52.99% | Alphatec Holdings |
| Revenue per Share (TTM) | $5 | $92 | Bio-Rad |
| Earnings per Share (Diluted) | $-1.13 | $11.08 | Bio-Rad |
| Beta (Stock Volatility) | 1.06 | 0.97 | Bio-Rad |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Alphatec Holdings vs Bio-Rad Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Alphatec Holdings | -2.58% | -7.80% | -16.77% | 24.43% | 35.86% | 50.11% |
| Bio-Rad | 0.00% | 0.00% | 15.31% | 13.92% | 17.72% | -12.51% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Alphatec Holdings | 164.08% | 50.11% | 34.52% | 206.31% | -54.67% | -85.69% |
| Bio-Rad | -14.92% | -36.76% | -46.25% | 111.13% | 215.90% | 430.01% |
News Based Sentiment: Alphatec Holdings vs Bio-Rad
Alphatec Holdings
News based Sentiment: MIXED
October presented a mixed bag for Alphatec, with stock declines and insider selling countered by oversold signals and upcoming earnings. The Q3 report on October 29th is a key catalyst that will determine the overall investment narrative, making this a moderately important month for the company.
Bio-Rad
News based Sentiment: NEGATIVE
Bio-Rad reported a slight decrease in both revenue and earnings per share for the first quarter of 2024. While not a dramatic decline, this signals potential challenges and warrants investor attention, making it an important, though not game-changing, development.
Performance & Financial Health Analysis: Alphatec Holdings vs Bio-Rad
| Metric | ATEC | BIO.B |
|---|---|---|
| Market Information | ||
| Market Cap | $2.22B | $8.41B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 1,642,697 | 40 |
| 90 Day Avg. Volume | 1,921,719 | 15 |
| Last Close | $13.60 | $284.88 |
| 52 Week Range | $4.88 - $16.70 | $225.29 - $359.22 |
| % from 52W High | -18.56% | -20.69% |
| All-Time High | $105.60 (Jun 12, 2006) | $818.60 (Sep 06, 2021) |
| % from All-Time High | -87.12% | -65.20% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.28% | 0.02% |
| Quarterly Earnings Growth | 0.27% | 0.02% |
| Financial Health | ||
| Profit Margin (TTM) | -0.24% | 0.13% |
| Operating Margin (TTM) | -0.06% | 0.12% |
| Return on Equity (TTM) | -3.77% | 0.05% |
| Debt to Equity (MRQ) | 1,238.29 | 19.73 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $0.16 | $263.42 |
| Cash per Share (MRQ) | $1.06 | $50.76 |
| Operating Cash Flow (TTM) | $15.69M | $534.20M |
| Levered Free Cash Flow (TTM) | $21.17M | $223.40M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Alphatec Holdings vs Bio-Rad
| Metric | ATEC | BIO.B |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -12.35 | 25.71 |
| Forward P/E | -21.48 | N/A |
| PEG Ratio | 1.79 | -0.22 |
| Price to Sales (TTM) | 3.03 | 3.10 |
| Price to Book (MRQ) | 86.17 | 1.08 |
| Market Capitalization | ||
| Market Capitalization | $2.22B | $8.41B |
| Enterprise Value | $2.52B | $7.74B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.69 | 3.03 |
| Enterprise to EBITDA | -167.82 | 18.87 |
| Risk & Other Metrics | ||
| Beta | 1.06 | 0.97 |
| Book Value per Share (MRQ) | $0.16 | $263.42 |
Financial Statements Comparison: Alphatec Holdings vs Bio-Rad
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ATEC | BIO.B |
|---|---|---|
| Revenue/Sales | $169.18M | $585.40M |
| Cost of Goods Sold | $53.18M | $279.40M |
| Gross Profit | $116.00M | $306.00M |
| Research & Development | $16.58M | $73.50M |
| Operating Income (EBIT) | $-31.71M | $23.70M |
| EBITDA | $-10.19M | $98.50M |
| Pre-Tax Income | $-51.97M | $83.40M |
| Income Tax | $-64,000 | $19.40M |
| Net Income (Profit) | $-51.91M | $64.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ATEC | BIO.B |
|---|---|---|
| Cash & Equivalents | $153.24M | $521.40M |
| Total Current Assets | $434.89M | $3.04B |
| Total Current Liabilities | $157.87M | $506.60M |
| Long-Term Debt | $572.40M | $1.33B |
| Total Shareholders Equity | $-85.94M | $6.68B |
| Retained Earnings | $-1.33B | $7.48B |
| Property, Plant & Equipment | $320.90M | $681.70M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ATEC | BIO.B |
|---|---|---|
| Operating Cash Flow | $-23.48M | $156.00M |
| Capital Expenditures | $-9.93M | $-34.40M |
| Free Cash Flow | $-16.65M | $95.50M |
| Debt Repayment | $-321.03M | $-100,000 |
| Common Stock Repurchase | $-3.00M | $-101.90M |
Short Interest & Institutional Ownership Analysis
| Metric | ATEC | BIO.B |
|---|---|---|
| Shares Short | 12.33M | 24 |
| Short Ratio | 6.08 | N/A |
| Short % of Float | 0.10% | 0.00% |
| Average Daily Volume (10 Day) | 1,642,697 | 40 |
| Average Daily Volume (90 Day) | 1,921,719 | 15 |
| Shares Outstanding | 144.13M | 28.01M |
| Float Shares | 116.52M | 21.67M |
| % Held by Insiders | 0.21% | 0.98% |
| % Held by Institutions | 0.69% | 0.00% |
Dividend Analysis & Yield Comparison: Alphatec Holdings vs Bio-Rad
| Metric | ATEC | BIO.B |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |